Health Watch Home
Health Care Value
Transparency Costs
Transparency Quallity
Health Care Competition
Freedom of Information
  Report an Incident
  Join Health Watch
 Search Health Watch
Subscribe to Health Watch USA's Newsletter

To contact Health Watch USA please  use the following E-Mail Address

Content in this website may be linked to, as long as the linking webpage and passage has a known and clearly stated author.


COVID-19 Vaccine Availability.    Back to OpEd Page

References:     View OpEd: 

1. Foley KE. The US could have 50 million vaccine doses before it’s ready to use them. Quartz. Oct. 29, 2020.
2. Weiland N. Zimmer. Pfizer’s Vaccine Offers Strong Protection After First Dose. New York Times. Dec. 8, 2020.
3. McGinley L, Abutaleb Y and Johnson CY. Pfizer tells U.S. officials it cannot supply substantial additional vaccine until late June or July. The Washington Post. Dec. 8, 2020.
4. Dooling K, McClung N, Chamberland M, et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020. MMWR. Dec. 3, 2020.
5. Aakash B, Faulconbridge G, Holton K. U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine. Reuters. May 21, 2020.
6. LaFraniere S. Thomas K, Weiland N. Trump administration officials passed when Pfizer offered months ago to sell the U.S. more vaccine doses. The New York Times. Dec. 7, 2020.
7. Wee SL. Chinese vaccine is 86 percent effective, says U.A.E. where trials were held. The New York Times. Dec. 9, 2020.
8. Branswell H, Herper M. Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy. STAT. Dec. 8, 2020.
9. Edney A. Pfizer Shot Effective, Safe, FDA Staff Says Before Meeting. Bloomberg. Dec. 8, 2020. 
10. Brenam M. Willingness to Get COVID-19 Vaccine Ticks Up to 63% in U.S. Gallup Poll. Dec. 8, 2020.